Erlotinib Active Not Recruiting Phase 2 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00491816Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer